Elevance Health, Inc (ELV) insider trading
Every open-market stock purchase and sale by Elevance Health, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $2.2M over the last 12 months (3 buys).
- Insiders sold $1.7M over the last 12 months (5 sales).
- Last insider buy: Gail Boudreaux (CEO), $753K, 3 months ago.
- Congress: Alan Armstrong bought $1K to $15K, 7 months ago.
Last 12 months: insiders bought $2.2M (3 buys) and sold $1.7M (5 sales). Last close $434.13 on Oct 21, 2026.
Recent ELV insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 2, 2026 | Mark Kaye (CFO) | Sold (not open market) | $1.6M |
| Oct 2, 2026 | Mark Kaye (CFO) | Bought (not open market) | — |
| Sep 3, 2026 | Erin M Wessling (C-suite exec) | Sold (not open market) | $106K |
| Sep 2, 2026 | Ryan R Craig (C-suite exec) | Sold (not open market) | $58.4K |
| Sep 2, 2026 | Erin M Wessling (C-suite exec) | Sold (not open market) | $38.1K |
| Jul 17, 2026 | Gail Boudreaux (CEO) | Bought | $753K |
| Jul 17, 2026 | Ramiro G Peru (Director) | Bought | $366K |
| Jul 17, 2026 | Gail Boudreaux (CEO) | Bought | $249K |
| Jun 12, 2026 | Ronald W Penczek (C-suite exec) | Sold | $149K |
| Jun 11, 2026 | Robert L Dixon JR (Director) | Sold | $60.7K |
| May 19, 2026 | Ronald W Penczek (C-suite exec) | Sold | $617K |
| May 19, 2026 | Ronald W Penczek (C-suite exec) | Bought (not open market) | — |
| May 19, 2026 | Ronald W Penczek (C-suite exec) | Bought (not open market) | — |
| May 13, 2026 | Ryan M. Schneider (Director) | Bought (not open market) | — |
| May 13, 2026 | Steven H Collis (Director) | Bought (not open market) | — |
| May 13, 2026 | Susan D. DeVore (Director) | Bought (not open market) | — |
| May 13, 2026 | Robert L Dixon JR (Director) | Bought (not open market) | — |
| May 13, 2026 | Lewis Hay III (Director) | Bought (not open market) | — |
| May 13, 2026 | Ramiro G Peru (Director) | Bought (not open market) | — |
| May 13, 2026 | Amy W Schulman (Director) | Bought (not open market) | — |
| May 13, 2026 | Deanna D Strable-Soethout (Director) | Bought (not open market) | — |
| May 13, 2026 | Antonio F Neri (Director) | Bought (not open market) | — |
| May 13, 2026 | Bahija Jallal (Director) | Bought (not open market) | — |
| Mar 27, 2026 | Alan Armstrong (Senator) | Bought | $1K–15K |
| Mar 12, 2026 | Amy W Schulman (Director) | Sold | $7.5K |
Who's trading ELV
- Mark Kaye, CFO: other filings, last Oct 2, 2026
- Erin M Wessling, C-suite exec: other filings, last Sep 3, 2026
- Ryan R Craig, C-suite exec: other filings, last Sep 2, 2026
- Gail Boudreaux, CEO: bought $1M (2 buys), last Jul 17, 2026
- Ramiro G Peru, Director: bought $366K (1 buy), last Jul 17, 2026
- Ronald W Penczek, C-suite exec: sold $766K (2 sales), last Jun 12, 2026
- Robert L Dixon JR, Director: sold $60.7K (1 sale), last Jun 11, 2026
- Susan D. DeVore, Director: other filings, last May 13, 2026
- Deanna D Strable-Soethout, Director: other filings, last May 13, 2026
- Amy W Schulman, Director: sold $7.5K (1 sale), last May 13, 2026
- Lewis Hay III, Director: other filings, last May 13, 2026
- Ryan M. Schneider, Director: other filings, last May 13, 2026
- Bahija Jallal, Director: other filings, last May 13, 2026
- Steven H Collis, Director: bought $870K (1 buy), last May 13, 2026
- Antonio F Neri, Director: other filings, last May 13, 2026
Get free alerts when an insider at Elevance Health, Inc files a new trade →